Table 1

Baseline features of the studied population according to the use of colchicine

Colchicine (−)
(n=96)
Colchicine (+)
(n=79)
P value
Gender, n (%)
 Female23 (24)21 (27)0.69
 Male73 (76)58 (73)
Age, mean (SD)45.1 (19.4)47.6 (20.8)0.40
Cardiovascular risk factors, n (%)63 (66)41 (52)0.066
Idiopathic/viral aetiology, n (%)88 (92)67 (85)0.16
Fever, n (%)53 (56)36 (46)0.18
Heart rate ≥70, n (%)63 (66)48 (61)0.51
ST-segment elevation, n (%)54 (56)22 (28)<0.001
EF>55%, n (%)79 (82)65 (82)1.00
Pericardial effusion, n (%)27 (28)41 (52)0.001
Leukocytosis, n (%)30 (32)46 (58)<0.001
Baseline troponin (ratio to 99° percentile)88±16359±1330.81
CRP (mg/dL), mean (SD)48.7 (49.9)68.9 (68.8)0.026
CRP>5, n (%)84 (88)68 (86)0.78
Myocardial oedema on CMR, n (%)28 (29)16 (20)0.18
Myocardial LGE on CMR, n (%)44 (46)36 (46)0.97
NSAIDs, n (%)90 (94)68 (86)0.088
Corticosteroids, n (%)18 (19)17 (22)0.65
  • CMR, cardiac magnetic resonance; CRP, C reactive protein; EF, ejection fraction; LGE, late gadolinium enhancement; NSAIDs, non-steroidal anti-inflammatory drugs.